WT1: A weak spot in KRAS-induced transformation

Journal of Clinical Investigation

Volumn 120, Issue 11, 2010, Pages 3804-3807

  Licciulli, Silvia ^a   Kissil, Joseph L ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; ARF PROTEIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; K RAS PROTEIN; POLO LIKE KINASE 1; PROTEIN P19; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE 33; SHORT HAIRPIN RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ALLELE; CELL PROLIFERATION; CELL TRANSFORMATION; CELL VIABILITY; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE MUTATION; GENE SILENCING; LETHAL GENE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; NONHUMAN; NOTE; ONCOGENE K RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SENESCENCE; TUMOR SUPPRESSOR GENE; WILMS TUMOR 1 GENE;

ANIMALS; CELL AGING; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICE; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); RAS PROTEINS; RNA, SMALL INTERFERING; WT1 PROTEINS;

EID: 78049451423     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44901     Document Type: Note

References (21)

1. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol. 2008;9(7):517-531.
2. Kaelin WG Jr. The concept of synthetic lethality in the context of anticancer therapy. Nat Rev Cancer. 2005;5(9):689-698.
3. Vicent S, et al. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. J Clin Invest. 2010; 120(11):3940-3952.
4. Westbrook TF, Stegmeier F, Elledge SJ. Dissecting cancer pathways and vulnerabilities with RNAi. Cold Spring Harb Symp Quant Biol. 2005;70:435-444.
5. Downward J. Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells. Oncogene. 2004;23(51):8376-8383.
6. Bernards R, Brummelkamp TR, Beijersbergen RL. shRNA libraries and their use in cancer genetics. Nat Methods. 2006;3(9):701-706.
7. Sharma S, Rao A. RNAi screening: tips and techniques. Nat Immunol. 2009;10(8):799-804.
8. Barbie DA, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108-112.
9. Luo J, et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell. 2009;137(5):835-848.
10. Scholl C, et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell. 2009;137(5):821-834.
11. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE. 2006; 2006(357):re13.
12. Rivera MN, Haber DA. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer. 2005;5(9):699-712.
13. Yang L, Han Y, Suarez Saiz F, Minden MD. A tumor suppressor and oncogene: the WT1 story. Leukemia. 2007;21(5):868-876. (Pubitemid 46672061)
14. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88(5):593-602. (Pubitemid 27152402)
15. Tuveson DA, et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and wide-spread neoplastic and developmental defects. Cancer Cell. 2004;5(4):375-387.
16. DeNicola GM, Tuveson DA. RAS in cellular transformation and senescence. Eur J Cancer. 2009;45(Suppl 1):211-216.
17. Young NP, Jacks T. Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras. Proc Natl Acad Sci U S A. 2010;107(22):10184-10189.
18. Braig M, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature. 2005;436(7051):660-665. (Pubitemid 41117262)
19. Chen Z, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005;436(7051):725-730. (Pubitemid 41117277)
20. Collado M, et al. Tumour biology: senescence in premalignant tumours. Nature. 2005;436(7051):642. (Pubitemid 41117258)
21. Michaloglou C, et al. BRAFE600-associated senescence- like cell cycle arrest of human naevi. Nature. 2005;436(7051):720-724. (Pubitemid 41117276)